Browsing restrictions can be lifted for a fee.
Qing Song Health Co.,Ltd. provides long-term care services in Taiwan. It offers community-based and residential care services. The company was founded in 1996 and is based in Taichung City, Taiwan.
6931
青松健康
-2.82%
(-0.03)
The most recent financial report for 青松健康 (6931) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 6931's short-term business performance and financial health. For the latest updates on 6931's earnings releases, visit this page regularly.
According to historical valuation range analysis, 青松健康 (6931)'s current price-to-earnings (P/E) ratio is 57.41, placing it in the Undervalued zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.
According to the latest financial report, 青松健康 (6931) reported an Operating Profit of 14.61M with an Operating Margin of 5.14% this period, representing a growth of 15.9% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
In the latest financial report, 青松健康 (6931) announced revenue of 284.49M, with a Year-Over-Year growth rate of 11.74%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
At the end of the period, 青松健康 (6931) held Total Cash and Cash Equivalents of 554.53M, accounting for 0.22 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
In the latest report, 青松健康 (6931) achieved the “three margins increasing” benchmark, with a gross margin of 12.63%%, operating margin of 5.14%%, and net margin of 11.28%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 6931's profit trajectory and future growth potential.
According to the past four quarterly reports, 青松健康 (6931)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 0.47. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.